Heres what you need to know about what really does, and doesnt, boost GLP-1
Much has been said about how GLP-1s are miracle drugs, providing myriad health benefits beyond weight loss or treating diabetes, lowering the risk of everything from heart disease to cognitive disorders
Abstract This large community-based cohort study investigates the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically Liraglutide and Semaglutide, on the risk of developing psychiatric conditions such as depression, anxiety, and suicidal behaviors in patients with obesity
She's always been skinny
TERN is also initiating IND-enabling activities in 2023 for TERN-800, an oral GIPR modulator , with the intention of being used in combination with GLP1R agonists
GLP-1 fatigue is a well-documented side effect that tends to worsen during periods of dosing instability